Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...

Truman Pierson and Christopher Fitz are developing behind-the-ear EEG patches and an accompanying app that issues an alert if ...

Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...

The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...

Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...

Severe liver injury cases prompt required liver function testing for patients taking the epilepsy drug as adjunctive therapy for focal seizures.

Oregon paramedics will start testing a drug that could some day let people treat long, dangerous seizures even before an ambulance arrives. If the test works, it could give a new anti-seizure tool not ...

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health to determine if the powerful anesthetic ...

Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...